Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national blog main
boston blog main
boston top stories
clinical trials
national top stories
san diego blog main
san diego top stories
startups
third rock ventures
vc
acetylon pharmaceuticals
ally bridge group
alnylam
ambys medicines
arena pharmaceuticals
artie suckow
big data analytics
biology
blackrock
boston
cancer
casdin capital
cell therapy
constellation pharmaceuticals
deals
diabetic nephropathy
drug delivery
dtx pharma
eventide asset management
financing
focal segmental glomerulosclerosis
gene therapy
genentech
goldfinch bio
holger willenbring
ipo
irving investors
jay ghosh
What
diseases
4
×
medicines
4
×
new
4
×
biotech
company
raises
rna
treat
addition
advance
aiming
alltrna
ambys
analysis
announced
based
betting
big
bio
biologics
bring
called
companies
considered
control
curious
deadly
deal
debuted
deliver
develop
developing
drug
drugs
dtx
employing
flagship
focus
following
formed
Language
unset
Current search:
medicines
×
diseases
×
new
×
@techcrunch.com
2 years ago
Flagship Pioneering’s new venture is betting on tRNA to treat “thousands of diseases”
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
4 years ago
DTx Pharma Raises $10.6M to Advance New Way to Deliver RNA Drugs
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?